back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-03-14 11:50 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,000
+200,000 vol $0.19 each |
600,000 | |
| Filed 2019-01-11 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$608,000
+400,000 vol $1.52 each |
400,000 | |
| Filed 2019-01-11 Tx date 2018-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-300,000
-200,000 vol $1.50 each |
0 | |
| Filed 2018-08-30 Tx date 2018-08-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-430,000
-200,000 vol $2.15 each |
20,000 | |
| Filed 2018-04-02 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2018-04-02 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-31 Tx date 2018-01-26 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
220,000 | |
| Filed 2018-01-31 Tx date 2018-01-26 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
200,000 | |
| Filed 2017-11-20 Tx date 2017-11-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-80,000 vol |
120,000 | |
| Filed 2016-12-27 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+200,000 vol $1.50 each |
300,000 | |
| Filed 2016-04-30 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2016-04-30 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
200,000 |